The FDA has approved azelastine HCI and fluticasone propionate nasal spray (Dymista, Meda) to treat seasonal allergic rhinitis. The approval comes after several clinical studies involving more than ...

Discover a study showing how nasal saline irrigation boosts symptom relief and quality of life in moderate-to-severe allergic rhinitis.

The School of Chinese Medicine (SCM) of Hong Kong Baptist University (HKBU) recently conducted a "Tianjiu therapy for allergic rhinitis: A double-blinded randomized Placebo-controlled clinical trial".

Glenmark Pharmaceuticals' subsidiary has received approval from China's National Medical Products Administration for RYALTRIS nasal spray, designed to treat allergic rhinitis. This approval marks a ...

Please provide your email address to receive an email when new articles are posted on . Researchers called this the first study among children aged 1 to 4 years. The treatment group saw improved ...

Glenmark Pharmaceuticals Ltd on Monday said its arm Glenmark Specialty SA has received approval from China's National Medical ...

Subcutaneous allergen-specific immunotherapy has long been used in allergic rhinitis and/or asthma and has been recognized to be efficacious. However, owing to the inconvenience of injection and the ...

Aptar Pharma and Dianosic Announce Exclusive Partnership to Advance the Active Resorbable Intranasal Scaffold Platform for the Treatment of Chronic Allergic Rhinitis and Chronic Rhinosinusitis ...

Glenmark's subsidiary receives China approval for Ryaltris nasal spray, enhancing treatment options for allergic rhinitis in ...

Over-the-counter (OTC) antihistamines like Zyrtec (cetirizine) and Claritin (loratadine) can help reduce allergy symptoms like itching, runny nose, sneezing, cough, flushing, nasal congestion, and ...

RYALTRIS is a first-of-its-kind fixed-dose combination nasal spray that brings together an olopatadine hydrochloride ...

Glenmark's RYALTRIS nasal spray receives NMPA approval in China for treating allergic rhinitis in adults and children.